Simon-Kucher & Partners

Simon-Kucher is a global strategy consulting firm specializing in pricing, marketing, sales, and growth strategies. The firm has deep expertise advising pharmaceutical, biotechnology, medical technology and healthcare companies on commercial strategy—including pricing and market access for new therapies—across all stages of the product lifecycle[6][10]. It does not itself conduct clinical trials or have its own drug pipeline.

The company’s healthcare practice helps clients with portfolio strategies, business model evolution, go-to-market planning and launch excellence for innovative products such as precision medicines and digital therapeutics[6][10].

With over four decades of experience in monetization topics across industries—and especially strong presence in life sciences—Simon-Kucher supports both established players and start-ups to unlock sustainable growth by commercializing advanced technologies that improve patient health outcomes[6][10].

Key recent leadership includes Co-Chief Executive Officers Joerg Kruetten and Dr. Gunnar Clausen (as of January 2025)[4][7].

The company operates globally with more than 2,000 employees across over 45 offices in more than 30 countries[1][2][3][4].